Pan Cancer T lands €10M to bring next-gen T-cell therapy to patients with deadly triple-negative breast cancer — TFN
Triple-negative breast most cancers (TNBC) is among the most aggressive breast most cancers subtypes, accounting for about 15% of diagnoses…
